The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Treatment of nonalcoholic fatty liver disease: role of AMPK
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a growing worldwide epidemic and an important risk factor for the development of insulin resistance, type 2 diabetes, nonalcoholic steatohepatitis (NASH), and hepatic cellular carcinoma (HCC). Despite the prevalence of NAFLD, lifestyle interventions involving exercise and weight loss are the only accepted treatments for this disease. Over the last decade, numerous experimental compounds have been shown to improve NAFLD in preclinical animal models, and many of these therapeutics have been shown to increase the activity of the cellular energy sensor AMP-activated protein kinase (AMPK). Because AMPK activity is reduced by inflammation, obesity, and diabetes, increasing AMPK activity has been viewed as a viable therapeutic strategy to improve NAFLD. In this review, we propose three primary mechanisms by which AMPK activation may improve NAFLD. In addition, we examine the mechanisms by which AMPK is activated. Finally, we identify 27 studies that have used AMPK activators to reduce NAFLD. Future considerations for studies examining the relationship between AMPK and NAFLD are highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 1×
“This decrease in glucose oxidation occurs because the acetyl-CoA generated via -oxidation inhibits pyruvate dehydrogenase (93).”
BackgroundDonnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Youle, R. J., & Narendra, D. P. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3028 · Cited by 3,273
Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
Egan, D. F., Shackelford, D. B., Mihaylova, M. M., Gelino, S., Kohnz, R. A., Mair, W., Vasquez, D. S., Joshi, A., Gwinn, D. M., Taylor, R., et al. (2011) · Science · doi:10.1126/science.1196371 · Cited by 2,600
The selectivity of protein kinase inhibitors: a further update
Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., Mclauchlan, H., Klevernic, I., Arthur, J. S. C., Alessi, D. R., & Cohen, P. (2007) · Biochemical Journal · doi:10.1042/bj20070797 · Cited by 2,520
Nonalcoholic Fatty Liver Disease: A Systematic Review
Rinella, M. E. (2015) · JAMA · doi:10.1001/jama.2015.5370 · Cited by 2,267
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157 · cited 4×
“The -subunit is referred to as a regulatory subunit due to its nucleotide-binding properties that modulate the allosteric control of AMPK, with ATP inhibiting and AMP and ADP activating the kinase (37, 123, 125).”
BackgroundInfluentialThe Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Li, Y., Xu, S., Mihaylova, M. M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, E., Shyy, J. Y.-J., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.009 · Cited by 1,778
Steinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637
Self-citationRegulation of hepatic fatty acid oxidation and ketone body production
McGarry, J. D., & Foster, D. W. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.002143 · Cited by 1,460 · cited 1×
“Therefore, AMPK activation increases fatty acid oxidation by increasing CPT I flux and the subsequent supply of fatty acids in the mitochondrial matrix (73).”
BackgroundEl-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322
Hawley, S. A., Davison, M., Woods, A., Davies, S. P., Beri, R. K., Carling, D., & Hardie, D. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27879 · Cited by 1,264
Disordered lipid metabolism and the pathogenesis of insulin resistance.
Savage, D. B., Petersen, K. F., & Shulman, G. I. (2007) · Physiological Reviews · doi:10.1152/physrev.00024.2006 · Cited by 1,107
Lambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069 · cited 2×
“This depression in DNL with a HFD is in direct contrast to the human condition, whereby DNL rates are elevated fivefold (17, 62).”
BackgroundResultSplanchnic lipolysis in human obesity
Nielsen, S., Guo, Z., Johnson, C. M., Hensrud, D. D., & Jensen, M. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21047 · Cited by 933
Structure of mammalian AMPK and its regulation by ADP
Xiao, B., Sanders, M. J., Underwood, E., Heath, R., Mayer, F. V., Carmena, D., Jing, C., Walker, P. A., Eccleston, J. F., Haire, L. F., et al. (2011) · Nature · doi:10.1038/nature09932 · Cited by 926
Cool, B., Zinker, B., Chiou, W., Kifle, L., Cao, N., Perham, M., Dickinson, R., Adler, A., Gagne, G., Iyengar, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.005 · Cited by 925
Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2
Abu-Elheiga, L., Matzuk, M. M., Abo-Hashema, K. A. H., & Wakil, S. J. (2001) · Science · doi:10.1126/science.1056843 · Cited by 903
Insulin resistance: a metabolic pathway to chronic liver disease
Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20920 · Cited by 900
Fullerton, M. D., Galic, S., Marcinko, K., Sikkema, S., Pulinilkunnil, T., Chen, Z.-P., O'Neill, H. M., Ford, R. J., Palanivel, R., O'Brien, M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3372 · Cited by 893
Self-citationBiguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
Miller, R. A., Chu, Q., Xie, J., Foretz, M., Viollet, B., & Birnbaum, M. J. (2013) · Nature · doi:10.1038/nature11808 · Cited by 833
Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation
Hawley, S. A., Ross, F. A., Chevtzoff, C., Green, K. A., Evans, A., Fogarty, S., Towler, M. C., Brown, L. J., Ogunbayo, O. A., Evans, A. M., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.001 · Cited by 773
The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase
Hawley, S. A., Fullerton, M. D., Ross, F. A., Schertzer, J. D., Chevtzoff, C., Walker, K. J., Peggie, M. W., Zibrova, D., Green, K. A., Mustard, K. J., et al. (2012) · Science · doi:10.1126/science.1215327 · Cited by 739
Self-citationPerry, R. J., Camporez, J.-P. G., Kursawe, R., Titchenell, P. M., Zhang, D., Perry, C. J., Jurczak, M. J., Abudukadier, A., Han, M. S., Zhang, X.-M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.012 · Cited by 719 · cited 2×
“In addition, an increase in free fatty acid delivery from white adipose tissue to the liver promotes fatty acid catabolism, which generates acetyl-CoA, which increases the activity of the gluconeogenic enzyme pyruvate carboxylase (4, 88).”
BackgroundMetformin in non-alcoholic steatohepatitis.
Marchesini, G., Bianchi, G., Tomassetti, S., Zoli, M., & Melchionda, N. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06042-1 · Cited by 682
Metformin reverses fatty liver disease in obese, leptin-deficient mice.
Lin, H. Z., Yang, S. Q., Chuckaree, C., Kuhajda, F., Ronnet, G., & Diehl, A. M. (2000) · Nature Medicine · doi:10.1038/79697 · Cited by 673
Min, H.-K., Kapoor, A., Fuchs, M., Mirshahi, F., Zhou, H., Maher, J., Kellum, J., Warnick, R., Contos, M. J., & Sanyal, A. J. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.004 · Cited by 652
AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol
Um, J.-H., Park, S.-J., Kang, H., Yang, S., Foretz, M., McBurney, M. W., Kim, M. K., Viollet, B., & Chung, J. H. (2010) · Diabetes · doi:10.2337/db09-0482 · Cited by 647
Structural basis for AMP binding to mammalian AMP-activated protein kinase
Xiao, B., Heath, R., Saiu, P., Leiper, F. C., Leone, P., Jing, C., Walker, P. A., Haire, L., Eccleston, J. F., Davis, C. T., et al. (2007) · Nature · doi:10.1038/nature06161 · Cited by 591
Structural basis of AMPK regulation by small molecule activators
Xiao, B., Sanders, M. J., Carmena, D., Bright, N. J., Haire, L. F., Underwood, E., Patel, B. R., Heath, R. B., Walker, P. A., Hallen, S., et al. (2013) · Nature Communications · doi:10.1038/ncomms4017 · Cited by 543
Gowans, G. J., Hawley, S. A., Ross, F. A., & Hardie, D. G. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.019 · Cited by 531 · cited 1×
“The -subunit is referred to as a regulatory subunit due to its nucleotide-binding properties that modulate the allosteric control of AMPK, with ATP inhibiting and AMP and ADP activating the kinase (37, 123, 125).”
BackgroundCrane, J. D., Palanivel, R., Mottillo, E. P., Bujak, A. L., Wang, H., Ford, R. J., Collins, A., Blümer, R. M., Fullerton, M. D., Yabut, J. M., et al. (2015) · Nature Medicine · doi:10.1038/nm.3766 · Cited by 490
Self-citationDzeja, P., & Terzic, A. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10041729 · Cited by 475
Biddinger, S. B., Hernandez-Ono, A., Rask-Madsen, C., Haas, J. T., Alemán, J. O., Suzuki, R., Scapa, E. F., Agarwal, C., Carey, M. C., Stephanopoulos, G., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.013 · Cited by 469
AMPK: A Target for Drugs and Natural Products With Effects on Both Diabetes and Cancer
Hardie, D. G. (2013) · Diabetes · doi:10.2337/db13-0368 · Cited by 458
The subcellular localization of acetyl-CoA carboxylase 2
Abu-Elheiga, L., Brinkley, W. R., Zhong, L., Chirala, S. S., Woldegiorgis, G., & Wakil, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1444 · Cited by 453
Zang, M., Zuccollo, A., Hou, X., Nagata, D., Walsh, K., Herscovitz, H., Brecher, P., Ruderman, N. B., & Cohen, R. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408149200 · Cited by 453
Savage, D. B. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27300 · Cited by 447
Gibala, M. J., McGee, S. L., Garnham, A. P., Howlett, K. F., Snow, R. J., & Hargreaves, M. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90880.2008 · Cited by 427
Steinberg, G. R., Michell, B. J., van Denderen, B. J. W., Watt, M. J., Carey, A. L., Fam, B. C., Andrikopoulos, S., Proietto, J., Görgün, C. Z., Carling, D., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.11.005 · Cited by 417
Self-citationO'Neill, H. M., Maarbjerg, S. J., Crane, J. D., Jeppesen, J., Jørgensen, S. B., Schertzer, J. D., Shyroka, O., Kiens, B., van Denderen, B. J., Tarnopolsky, M. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105062108 · Cited by 406
Self-citationMetformin in the treatment of patients with non‐alcoholic steatohepatitis
Uygun, A., Kadayifci, A., Isik, A. T., Ozgurtas, T., Deveci, S., Tuzun, A., Yesilova, Z., Gulsen, M., & Dagalp, K. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01888.x · Cited by 405
Park, H., Kaushik, V. K., Constant, S., Prentki, M., Przybytkowski, E., Ruderman, N. B., & Saha, A. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201692200 · Cited by 384
Functional Domains of the α1 Catalytic Subunit of the AMP-activated Protein Kinase
Crute, B. E., Seefeld, K., Gamble, J., Kemp, B. E., & Witters, L. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35347 · Cited by 368
Mitochondrial dysfunction in white adipose tissue
Kusminski, C. M., & Scherer, P. E. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.06.004 · Cited by 362
NAFLD in children: A prospective clinical-pathological study and effect of lifestyle advice
Nobili, V., Marcellini, M., Devito, R., Ciampalini, P., Piemonte, F., Comparcola, D., Sartorelli, M. R., & Angulo, P. (2006) · Hepatology · doi:10.1002/hep.21262 · Cited by 352
Sanders, M. J., Ali, Z. S., Hegarty, B. D., Heath, R., Snowden, M. A., & Carling, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706543200 · Cited by 347
Chen, Z.-P., McConell, G. K., Michell, B. J., Snow, R. J., Canny, B. J., & Kemp, B. E. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.5.e1202 · Cited by 342
Galic, S., Fullerton, M. D., Schertzer, J. D., Sikkema, S., Marcinko, K., Walkley, C. R., Izon, D., Honeyman, J., Chen, Z.-P., van Denderen, B. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58577 · Cited by 342
Self-citationFrom NAFLD in clinical practice to answers from guidelines
Nascimbeni, F., Pais, R., Bellentani, S., Day, C. P., Ratziu, V., Loria, P., & Lonardo, A. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.05.044 · Cited by 337
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
Haukeland, J. W., Konopski, Z., Eggesbø, H. B., von Volkmann, H. L., Raschpichler, G., Bjøro, K., Haaland, T., Løberg, E. M., & Birkeland, K. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520902845268 · Cited by 323
Mottillo, E. P., Desjardins, E. M., Crane, J. D., Smith, B. K., Green, A. E., Ducommun, S., Henriksen, T. I., Rebalka, I. A., Razi, A., Sakamoto, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.006 · Cited by 321
Self-citationEffect of aerobic exercise training dose on liver fat and visceral adiposity
Keating, S. E., Hackett, D. A., Parker, H. M., O’Connor, H. T., Gerofi, J. A., Sainsbury, A., Baker, M. K., Chuter, V. H., Caterson, I. D., George, J., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.022 · Cited by 313 · cited 2×
“These interventions, while efficacious if followed, have high attrition rates (57, 63).”
BackgroundMUNDAY, M. R., CAMPBELL, D. G., CARLING, D., & HARDIE, D. G. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14201.x · Cited by 308
Role of leisure-time physical activity in nonalcoholic fatty liver disease: A population-based study
Zelber-Sagi, S., Nitzan-Kaluski, D., Goldsmith, R., Webb, M., Zvibel, I., Goldiner, I., Blendis, L., Halpern, Z., & Oren, R. (2008) · Hepatology · doi:10.1002/hep.22525 · Cited by 296
Hart, S. N., Li, Y., Nakamoto, K., Subileau, E.-A., Steen, D., & Zhong, X.-B. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.031831 · Cited by 296
Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes
Goldfine, A. B., Silver, R., Aldhahi, W., Cai, D., Tatro, E., Lee, J., & Shoelson, S. E. (2008) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2008.00026.x · Cited by 294
Zhang, D., Liu, Z.-X., Choi, C. S., Tian, L., Kibbey, R., Dong, J., Cline, G. W., Wood, P. A., & Shulman, G. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707060104 · Cited by 291
Niclosamide ethanolamine–induced mild mitochondrial uncoupling improves diabetic symptoms in mice
Tao, H., Zhang, Y., Zeng, X., Shulman, G. I., & Jin, S. (2014) · Nature Medicine · doi:10.1038/nm.3699 · Cited by 288
Harriman, G., Greenwood, J., Bhat, S., Huang, X., Wang, R., Paul, D., Tong, L., Saha, A. K., Westlin, W. F., Kapeller, R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520686113 · Cited by 287 · cited 1×
“In support of the importance of ACC phosphorylation, Nimbus pharmaceuticals has recently developed a small molecule that binds to ACC and mimics the effects of AMPK phosphorylation (inhibition of ACC dimerization) to inhibit ACC activity and reduce malonyl-CoA (42).”
BackgroundControlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats
Perry, R. J., Zhang, D., Zhang, X.-M., Boyer, J. L., & Shulman, G. I. (2015) · Science · doi:10.1126/science.aaa0672 · Cited by 283
McGarry, J. D., Takabayashi, Y., & Foster, D. W. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34395-8 · Cited by 274
Scott, J. W., van Denderen, B. J. W., Jorgensen, S. B., Honeyman, J. E., Steinberg, G. R., Oakhill, J. S., Iseli, T. J., Koay, A., Gooley, P. R., Stapleton, D., et al. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.10.005 · Cited by 252
Self-citationSalicylate (Salsalate) in Patients With Type 2 Diabetes: A Randomized Trial
Goldfine, A. B., Fonseca, V., Jablonski, K. A., Chen, Y.-D. I., Tipton, L., Staten, M. A., & Shoelson, S. E. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-1-201307020-00003 · Cited by 251 · cited 1×
“A prodrug of salicylate known as salsalate is currently in phase 3 clinical trials for type 2 diabetes (33), and although it was hypothesized that this drug would improve glucose homeostasis by reducing adipose tissue inflammation, hyperinsulinemic euglycemic clamp studies suggest the primary organ responsible for the…”
BackgroundInterplay between FGF21 and insulin action in the liver regulates metabolism
Emanuelli, B., Vienberg, S. G., Smyth, G., Cheng, C., Stanford, K. I., Arumugam, M., Michael, M. D., Adams, A. C., Kharitonenkov, A., & Kahn, C. R. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67353 · Cited by 245
Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids
Vatner, D. F., Majumdar, S. K., Kumashiro, N., Petersen, M. C., Rahimi, Y., Gattu, A. K., Bears, M., Camporez, J.-P. G., Cline, G. W., Jurczak, M. J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423952112 · Cited by 235
Perry, R. J., Kim, T., Zhang, X.-M., Lee, H.-Y., Pesta, D., Popov, V. B., Zhang, D., Rahimi, Y., Jurczak, M. J., Cline, G. W., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.004 · Cited by 230
Xu, X. J., Gauthier, M.-S., Hess, D. T., Apovian, C. M., Cacicedo, J. M., Gokce, N., Farb, M., Valentine, R. J., & Ruderman, N. B. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p022905 · Cited by 229
Larson‐Meyer, D. E., Newcomer, B. R., Heilbronn, L. K., Volaufova, J., Smith, S. R., Alfonso, A. J., Lefevre, M., Rood, J. C., Williamson, D. A., Ravussin, E., et al. (2008) · Obesity · doi:10.1038/oby.2008.201 · Cited by 215
Gauthier, M.-S., O’Brien, E. L., Bigornia, S., Mott, M., Cacicedo, J. M., Xu, X. J., Gokce, N., Apovian, C., & Ruderman, N. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.127 · Cited by 213
Liver ATP Synthesis Is Lower and Relates to Insulin Sensitivity in Patients With Type 2 Diabetes
Schmid, A. I., Szendroedi, J., Chmelik, M., Krššák, M., Moser, E., & Roden, M. (2011) · Diabetes Care · doi:10.2337/dc10-1076 · Cited by 212
A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis
Zadra, G., Photopoulos, C., Tyekucheva, S., Heidari, P., Weng, Q. P., Fedele, G., Liu, H., Scaglia, N., Priolo, C., Sicinska, E., et al. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201302734 · Cited by 204
Stefanovic-Racic, M., Perdomo, G., Mantell, B. S., Sipula, I. J., Brown, N. F., & O'Doherty, R. M. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00497.2007 · Cited by 192
The Role of Metformin in the Management of NAFLD
Mazza, A., Fruci, B., Garinis, G. A., Giuliano, S., Malaguarnera, R., & Belfiore, A. (2012) · Experimental Diabetes Research · doi:10.1155/2012/716404 · Cited by 184
Regulation of AMP-activated protein kinase by natural and synthetic activators
Grahame Hardie, D. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.06.002 · Cited by 174
Ford, R. J., Fullerton, M. D., Pinkosky, S. L., Day, E. A., Scott, J. W., Oakhill, J. S., Bujak, A. L., Smith, B. K., Crane, J. D., Blümer, R. M. E., et al. (2015) · Biochemical Journal · doi:10.1042/bj20150125 · Cited by 172
Self-citationResveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway
Zhang, Y., Chen, M., Zhou, Y., Yi, L., Gao, Y., Ran, L., Chen, S., Zhang, T., Zhou, X., Zou, D., et al. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500016 · Cited by 170
Duarte, J. A. G., Carvalho, F., Pearson, M., Horton, J. D., Browning, J. D., Jones, J. G., & Burgess, S. C. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m052308 · Cited by 170
Concurrent exercise prevents high-fat-diet-induced macrovesicular hepatic steatosis
Gauthier, M.-S., Couturier, K., Latour, J.-G., & Lavoie, J.-M. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01164.2002 · Cited by 167
Regulation and function of triacylglycerol lipases in cellular metabolism
Watt, M. J., & Steinberg, G. R. (2008) · Biochemical Journal · doi:10.1042/bj20080305 · Cited by 165
Self-citationHwang, Y. P., Choi, J. H., Han, E. H., Kim, H. G., Wee, J., Jung, K. O., Jung, K. H., Kwon, K., Jeong, T. C., Chung, Y., et al. (2011) · Nutrition Research · doi:10.1016/j.nutres.2011.09.026 · Cited by 163
Iseli, T. J., Walter, M., van Denderen, B. J. W., Katsis, F., Witters, L. A., Kemp, B. E., Michell, B. J., & Stapleton, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412993200 · Cited by 162
Streba, L. A. M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i14.4103 · Cited by 161
Gadalla, A. E., Pearson, T., Currie, A. J., Dale, N., Hawley, S. A., Sheehan, M., Hirst, W. D., Michel, A. D., Randall, A. D., Hardie, D. G., et al. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02253.x · Cited by 158
Scott, J. W., Ling, N., Issa, S. M. A., Dite, T. A., O’Brien, M. T., Chen, Z.-P., Galic, S., Langendorf, C. G., Steinberg, G. R., Kemp, B. E., et al. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.03.006 · Cited by 158
Self-citationHigh intensity interval training improves liver and adipose tissue insulin sensitivity
Marcinko, K., Sikkema, S. R., Samaan, M. C., Kemp, B. E., Fullerton, M. D., & Steinberg, G. R. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.09.006 · Cited by 156
Self-citationHydrogen sulfide reduces serum triglyceride by activating liver autophagy via the AMPK-mTOR pathway
Sun, L., Zhang, S., Yu, C., Pan, Z., Liu, Y., Zhao, J., Wang, X., Yun, F., Zhao, H., Yan, S. R., et al. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00294.2015 · Cited by 137
Hepatic De Novo Lipogenesis Is Present in Liver-Specific ACC1-Deficient Mice
Harada, N., Oda, Z., Hara, Y., Fujinami, K., Okawa, M., Ohbuchi, K., Yonemoto, M., Ikeda, Y., Ohwaki, K., Aragane, K., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01122-06 · Cited by 134
Chronic Activation of γ2 AMPK Induces Obesity and Reduces β Cell Function
Yavari, A., Stocker, C. J., Ghaffari, S., Wargent, E. T., Steeples, V., Czibik, G., Pintér, K., Bellahcene, M., Woods, A., de Morentin, P. B. M., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.003 · Cited by 120
Sachithanandan, N., Fam, B. C., Fynch, S., Dzamko, N. L., Watt, M. J., Wormald, S., Honeyman, J. E., Galić, S., Proietto, J., Andrikopoulos, S., et al. (2010) · Hepatology · doi:10.1002/hep.23861 · Cited by 118
Self-citationNiu, Y., Li, S., Na, L., Feng, R., Liu, L., Li, Y., & Sun, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030782 · Cited by 116
Chow, J. D. Y., Lawrence, R., Healy, M. E., Dominy, J. E., Liao, J. A., Breen, D. S., Byrne, F. L., Kenwood, B. M., Lackner, C., Okutsu, S., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.02.004 · Cited by 116
Lai, Y., Kviklyte, S., Vertommen, D., Lantier, L., Foretz, M., Viollet, B., Hallén, S., & Rider, M. H. (2014) · Biochemical Journal · doi:10.1042/bj20131673 · Cited by 106
AMPK activation with glabridin ameliorates adiposity and lipid dysregulation in obesity
Lee, J.-W., Choe, S. S., Jang, H., Kim, J., Jeong, H. W., Jo, H., Jeong, K.-H., Tadi, S., Park, M. G., Kwak, T. H., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m022897 · Cited by 104
Chung, S. H. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.805 · Cited by 103
Qiang, X., Xu, L., Zhang, M., Zhang, P., Wang, Y., Wang, Y., Zhao, Z., Chen, H., Liu, X., & Zhang, Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.03.019 · Cited by 101
A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis
Gomez‐Galeno, J., Dang, Q., Nguyen, T. H., Boyer, S. H., Grote, M. P., Sun, Z., Chen, M., Craigo, W. A., van Poelje, P. D., MacKenna, D. A., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100143q · Cited by 100
Nonalcoholic fatty liver disease decrease in obese adolescents after multidisciplinary therapy
Tock, L., do Prado, W. L., Caranti, D. A., Cristofalo, D. M. J., Lederman, H. M., Fisberg, M., Siqueira, K. L. O., Stella, S. R. G., Antunes, H. K. M., Cintra, I. P., et al. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/01.meg.0000243872.86949.95 · Cited by 99
Hoene, M., Lehmann, R., Hennige, A. M., Pohl, A. K., Häring, H. U., Schleicher, E. D., & Weigert, C. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.160275 · Cited by 98
Sato, S., Jung, H., Nakagawa, T., Pawlosky, R. J., Takeshima, T., Lee, W.-R., Sakiyama, H., Laxman, S., Wynn, R., Tu, B. P., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.708982 · Cited by 96
Seo, M. S., Kim, J. H., Kim, H. J., Chang, K. C., & Park, S. W. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.02.020 · Cited by 93
Hasenour, C. M., Ridley, D. E., Hughey, C. C., James, F. D., Donahue, E. P., Shearer, J., Viollet, B., Foretz, M., & Wasserman, D. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.528232 · Cited by 88
Enhanced activation of cellular AMPK by dual-small molecule treatment: AICAR and A769662
Ducommun, S., Ford, R. J., Bultot, L., Deák, M., Bertrand, L., Kemp, B. E., Steinberg, G. R., & Sakamoto, K. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00672.2013 · Cited by 88
Self-citationSystematic review: Preventive and therapeutic applications of metformin in liver disease
Bhat, A., Sebastiani, G., & Bhat, M. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i12.1652 · Cited by 88
Molecular mechanism for the regulation of human ACC2 through phosphorylation by AMPK
Cho, Y. S., Lee, J. I., Shin, D., Kim, H. T., Jung, H. Y., Lee, T. G., Kang, L., Ahn, Y., Cho, H., & Heo, Y.-S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.029 · Cited by 87
Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A
Jung, T. W., Youn, B., Choi, H. Y., Lee, S. Y., Hong, H. C., Yang, S. J., Yoo, H. J., Kim, B., Baik, S. H., & Choi, K. M. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.034 · Cited by 86
Smith, B. K., Ford, R. J., Desjardins, E. M., Green, A. E., Hughes, M. C., Houde, V. P., Day, E. A., Marcinko, K., Crane, J. D., Mottillo, E. P., et al. (2016) · Diabetes · doi:10.2337/db16-0564 · Cited by 79
Self-citationCordycepin activates AMP ‐activated protein kinase ( AMPK ) via interaction with the γ1 subunit
Wu, C., Guo, Y., Su, Y., Zhang, X., Luan, H., Zhang, X., Zhu, H., He, H.-X., Wang, X., Sun, G., et al. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12187 · Cited by 79
Bojic, L. A., Telford, D. E., Fullerton, M. D., Ford, R. J., Sutherland, B. G., Edwards, J. Y., Sawyez, C. G., Gros, R., Kemp, B. E., Steinberg, G. R., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m046037 · Cited by 78
Self-citationYoshimura, E., Kumahara, H., Tobina, T., Matsuda, T., Ayabe, M., Kiyonaga, A., Anzai, K., Higaki, Y., & Tanaka, H. (2014) · Journal of Obesity · doi:10.1155/2014/197216 · Cited by 73
Hwang, H.-J., Jung, T. W., Kim, B.-H., Hong, H. C., Seo, J. A., Kim, S. G., Kim, N. H., Choi, K. M., Choi, D. S., Baik, S. H., et al. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.08.098 · Cited by 72
Jung, T. W., Hong, H. C., Hwang, H., Yoo, H. J., Baik, S. H., & Choi, K. M. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.09.027 · Cited by 72
Scott, J. W., Galić, S., Graham, K. L., Foitzik, R. C., Ling, N. X. Y., Dite, T. A., Issa, S. M. A., Langendorf, C. G., Weng, Q. P., Thomas, H. E., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.05.011 · Cited by 65
Self-citationCardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation
Castaño, D., Larequi, E., Belza, I., Astudillo, A. M., Martínez‐Ansó, E., Balsinde, J., Argemí, J., Aragón, T., Moreno-Aliaga, M. J., Muntané, J., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.012 · Cited by 65
Gonçalves, I. O., Passos, E., Rocha‐Rodrigues, S., Diogo, C. V., Torrella, J. R., Rizo‐Roca, D., Viscor, G., Alves, E. S., Marques‐Aleixo, I., Oliveira, P. J., et al. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.03.012 · Cited by 63
AMPK-dependent modulation of hepatic lipid metabolism by nesfatin-1
Yin, Y., Li, Z., Gao, L., Li, Y., Zhao, J., & Zhang, W. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.09.006 · Cited by 62
Sid, V., Wu, N., Sarna, L. K., Siow, Y. L., House, J. D., & Karmin, O. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00260.2015 · Cited by 61
Kim, D., Kim, M., Sa, B.-K., Kim, M., & Hwang, J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13010994 · Cited by 60
Changes in fat synthesis influenced by dietary macronutrient content
Parks, E. J. (2002) · Proceedings of The Nutrition Society · doi:10.1079/pns2002148 · Cited by 56
Henriksen, B. S., Curtis, M. E., Fillmore, N., Cardon, B. R., Thomson, D. M., & Hancock, C. R. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-29 · Cited by 52
Choi, Y., Suh, H.-R., Yoon, Y., Lee, K. J., Kim, D. G., Kim, S., & Lee, B. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0347-z · Cited by 50
Zhang, S., Li, Y.-F., Wang, G.-E., Tan, R., Tsoi, B., Mao, G., Zhai, Y.-J., Cao, L., Chen, M., Kurihara, H., et al. (2015) · Food & Function · doi:10.1039/c5fo00247h · Cited by 47
Lee, M.-S., Kim, D., Jo, K., & Hwang, J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.016 · Cited by 44
Figarola, J. L., Singhal, J., Tompkins, J. D., Rogers, G. W., Warden, C., Horne, D., Riggs, A. D., Awasthi, S., & Singhal, S. S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.686352 · Cited by 41
Zhang, H.-A., Yang, X., & Xiao, Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.04.111 · Cited by 37
Sheldon, R. D., Laughlin, M. H., & Rector, R. S. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01275.2013 · Cited by 35
Cassia tora (Leguminosae) seed extract alleviates high-fat diet-induced nonalcoholic fatty liver
Tzeng, T., Lu, H.-J., Liou, S., Chang, C. J., & Liu, I.-M. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.09.024 · Cited by 34
Figarola, J. L., Singhal, P., Rahbar, S., Gugiu, B. G., Awasthi, S., & Singhal, S. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083801 · Cited by 32
Overexpression of AMPKα1 Ameliorates Fatty Liver in Hyperlipidemic Diabetic Rats
Seo, E., Park, E. J., Joe, Y., Kang, S., Kim, M.-S., Hong, S. H., Park, M., Kim, D. K., Koh, H., & Lee, H. (2009) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2009.13.6.449 · Cited by 31
Liang, W., Verschuren, L., Mulder, P., van der Hoorn, J. W. A., Verheij, J., van Dam, A. D., Boon, M. R., Princen, H. M. G., Havekes, L. M., Kleemann, R., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13315 · Cited by 31
Linden, M. A., Meers, G. M.-E., Ruebel, M. L., Jenkins, N. T., Booth, F. W., Laughlin, M. H., Ibdah, J. A., Thyfault, J. P., & Rector, R. S. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00537.2012 · Cited by 30
Koch, J. E., Ji, H. L., Osbakken, M. D., & Friedman, M. I. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.3.r610 · Cited by 30
Apparent co-operative effect of acetyl-CoA on sheep kidney pyruvate carboxylase
Barritt, G. J., KEECH, D. B., & Ai-Mee-Ling (1966) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(66)90186-0 · Cited by 29
Moon, H. Y., Song, P., Choi, C. S., Ryu, S. H., & Suh, P. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0135 · Cited by 22
Clinical trial success rates of anti‐obesity agents: the importance of combination therapies
Hussain, H. T., Parker, J. L., & Sharma, A. M. (2015) · Obesity Reviews · doi:10.1111/obr.12299 · Cited by 17
Cited by
AMPK: guardian of metabolism and mitochondrial homeostasis
Herzig, S., & Shaw, R. J. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.95 · Cited by 4,061
AMP-activated protein kinase: the current landscape for drug development
Steinberg, G. R., & Carling, D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0019-2 · Cited by 754
Self-citationHepatokines: Linking nonalcoholic fatty liver disease and insulin resistance
Meex, R. C. R., & Watt, M. J. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.56 · Cited by 631
AMPK as a Therapeutic Target for Treating Metabolic Diseases
Day, E. A., Ford, R. J., & Steinberg, G. R. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.05.004 · Cited by 619
Self-citationA Molecular Approach to Mitophagy and Mitochondrial Dynamics.
Yoo, S., & Jung, Y. (2018) · PubMed · doi:10.14348/molcells.2018.2277 · Cited by 441
Metadata
- Authors
- Smith, B. K., Marcinko, K., Desjardins, E. M., Lally, J. S., Ford, R. J., & Steinberg, G. R.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2016-10-01
- Volume
- 311
- Issue
- 4
- Pages
- E730-E740
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2530564279
- Cited by
- 500
- References
- 138
- FWCI
- 26.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.